Automatic Feedback Indicator to Enhance the Hospital Discharge Communication Between Acute Care and Primary Care.
NCT ID: NCT06835153
Last Updated: 2025-02-19
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
NA
132000 participants
INTERVENTIONAL
2025-03-01
2026-02-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The study will be conducted at Grenoble Alpes University Hospital and involve 40 hospital services across three campuses. The trial design includes two parallel arms: an intervention group receiving monthly performance feedback through automated dashboards and a control group with no additional intervention. Services are randomized into these groups using a stratified cluster approach.
The primary objective is to assess whether this intervention increases the proportion of discharge letters validated on the day of discharge compared to usual care. Secondary objectives include evaluating patient satisfaction, rates of unplanned 30-day readmissions, and completeness of discharge letter content.
The study will include data from approximately 132,000 patient stays over two phases: a pre-implementation observational period (12 months) and an intervention phase (12 months). All data will be collected and analyzed anonymously, with findings expected to inform the broader implementation of quality improvement strategies in French hospitals.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
An Automatic Notification System for Test Results Finalized After Discharge
NCT01153451
Precision Feedback to Improve Health Care Quality
NCT05923463
Randomized Controlled Trial of Multi-Source Feedback to Pediatric Residents
NCT00302783
The Effects of a Results Management System on Physician Awareness of Post-Discharge Test Results
NCT00146354
Multifaceted Program to Improve Interpersonal Skills of Physicians
NCT04703816
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
This study seeks to address this gap through an automated feedback mechanism. Using the hospital's electronic health record (EHR) system, the study will generate monthly dashboards for each participating service in the intervention group. These dashboards will provide a real-time view of performance metrics, including the proportion of discharge letters validated on the day of discharge and the completeness of required content fields.
The trial employs a cluster-randomized controlled design with 40 hospital services as the unit of randomization. Services are stratified by activity type (medicine, surgery/obstetrics) and baseline performance. The study is divided into two phases:
Pre-implementation Phase (January 2024 - January 2025): A 12-month observational period to collect baseline data and stratify services for randomization.
Implementation Phase (February 2025 - February 2026): Intervention services receive monthly performance feedback, while control services continue with standard care practices.
The primary endpoint is the proportion of hospital stays where discharge letters are validated on the day of discharge. Secondary outcomes include:
Patient satisfaction, measured through the national "e-Satis" survey. Rates of unplanned readmissions within 30 days of discharge. Completeness of discharge letters, evaluated across mandated content fields (e.g., patient identification, discharge summary, follow-up plan).
This study will enroll all eligible patient stays within the 40 participating services, excluding stays of less than 24 hours or cases where the patient died during hospitalization. The anticipated sample size is 132,000 stays.
Data collection will rely on routine administrative data from the EHR system, anonymized at the patient level. Statistical analyses will adopt a "difference-in-differences" approach, comparing changes in outcomes between the intervention and control groups over time. A mixed-effects logistic regression model will account for intra-cluster correlations.
The results of this study aim to demonstrate the effectiveness of automated feedback in driving quality improvements in hospital discharge processes. If successful, the approach could be scaled across other hospitals in France, contributing to better continuity of care and patient outcomes.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
The intervention arm will receive monthly feedback via automated performance dashboards, highlighting the proportion of discharge letters validated on the day of discharge and the completeness of required content fields. The control arm will not receive any feedback but will continue routine care practices.
Outcomes will be assessed over two phases: a 12-month pre-implementation observational phase and a 12-month intervention phase. The analysis uses a "difference-in-differences" approach to compare changes in outcomes between the two groups, accounting for intra-cluster correlations using mixed-effects logistic regression models.
HEALTH_SERVICES_RESEARCH
SINGLE
Outcomes assessors and the statistician will work with anonymized datasets without group allocation information. However, participants (hospital services), care providers, and investigators managing the intervention are not masked due to the need to deliver feedback in real-time and monitor its implementation.
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Intervention Group
Hospital services in this group will receive monthly performance feedback through automated dashboards, provided electronically to the entire service team, including all physicians, nurse managers, and secretarial staff. These dashboards will display data on the proportion of discharge letters validated on the day of discharge and the completeness of required content fields. The intervention also includes support from a designated quality improvement officer, who will assist teams in implementing organizational changes as needed to improve performance.
Monthly Performance Feedback with Dashboards (Automated Audit and Feedback)
Hospital services in the intervention group will receive monthly automated dashboards that provide detailed performance metrics. These include:
The proportion of patients with a discharge letter generated on the day of discharge, The proportion of discharge letters validated on the day of discharge, Median delays for generating discharge letters, Median delays for validating discharge letters. The dashboards are shared with all physicians, nurse managers, and secretarial staff in each service. A designated quality improvement officer is available to assist teams in interpreting the data and implementing organizational changes based on the feedback. The intervention uses real-time data extraction from the hospital's electronic health record system to generate these insights.
Control Group with Usual Care
Hospital services in this group will continue with usual care practices and may access routine support from institutional departments, such as quality management and IT services, upon request. However, no automated feedback on discharge letter performance will be provided or proposed. This setup ensures the control group reflects the typical resources and support available in standard practice.
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Monthly Performance Feedback with Dashboards (Automated Audit and Feedback)
Hospital services in the intervention group will receive monthly automated dashboards that provide detailed performance metrics. These include:
The proportion of patients with a discharge letter generated on the day of discharge, The proportion of discharge letters validated on the day of discharge, Median delays for generating discharge letters, Median delays for validating discharge letters. The dashboards are shared with all physicians, nurse managers, and secretarial staff in each service. A designated quality improvement officer is available to assist teams in interpreting the data and implementing organizational changes based on the feedback. The intervention uses real-time data extraction from the hospital's electronic health record system to generate these insights.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients discharged alive directly from participating services.
Exclusion Criteria
* Patients who died during hospitalization.
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital, Grenoble
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Bastien Boussat, MD PhD
Role: PRINCIPAL_INVESTIGATOR
Grenoble Alps University, Faculty of Medicine.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Centre hospitalier de Grenoble Alpes
Grenoble, , France
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
PREPS-20-0195
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.